Concepts (306)
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with LEONID METELITSA's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that LEONID METELITSA has written about over time.
Killer Cells, NaturalAntigens, CD1dCancer VaccinesNeuroblastomaLymphocyte ActivationCytotoxicity, ImmunologicImmunotherapyReceptors, Antigen, T-CellMice, SCIDGangliosidesLymphoma, B-CellXenograft Model Antitumor AssaysInterleukin-15Natural Killer T-CellsNeoplasmsImmunotherapy, AdoptiveReceptors, Tumor Necrosis Factor, Type IIImmunologic MemoryPositive Regulatory Domain I-Binding Factor 1
To see the data from this visualization as text,
click here.
| Name | Number of Publications | First Publication Year | Most Recent Publication Year | Average Publication Date |
|---|
| Killer Cells, Natural | 9 | 2001 | 2023 | March 2008 |
| Antigens, CD1d | 9 | 2001 | 2024 | February 2011 |
| Cancer Vaccines | 5 | 2010 | 2019 | January 2014 |
| Neuroblastoma | 25 | 2000 | 2025 | January 2014 |
| Lymphocyte Activation | 13 | 2001 | 2024 | August 2014 |
| Cytotoxicity, Immunologic | 12 | 2001 | 2024 | September 2014 |
| Immunotherapy | 5 | 2010 | 2019 | November 2014 |
| Receptors, Antigen, T-Cell | 10 | 2001 | 2023 | April 2015 |
| Mice, SCID | 10 | 2007 | 2023 | May 2015 |
| Gangliosides | 5 | 2002 | 2025 | February 2016 |
| Lymphoma, B-Cell | 3 | 2016 | 2018 | March 2017 |
| Xenograft Model Antitumor Assays | 11 | 2007 | 2025 | April 2017 |
| Interleukin-15 | 7 | 2004 | 2025 | December 2017 |
| Natural Killer T-Cells | 20 | 2009 | 2025 | July 2018 |
| Neoplasms | 6 | 2010 | 2024 | December 2019 |
| Immunotherapy, Adoptive | 16 | 2012 | 2025 | November 2020 |
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2023 | 2023 | February 2023 |
| Immunologic Memory | 1 | 2025 | 2025 | March 2025 |
| Positive Regulatory Domain I-Binding Factor 1 | 1 | 2025 | 2025 | March 2025 |
To return to the timeline,
click here.